Featured
In the News
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Alto Neuroscience continues march toward the clinic with Series B, hoping to unveil data next year
Subscription Required
October 25, 2022
Alto Neuroscience continues march toward the clinic with Series B, hoping to unveil data next year
October 25, 2022
2022
Harnessing the creative energy of California, Alto is advancing a novel approach to psychiatric meds
October 11, 2022
Harnessing the creative energy of California, Alto is advancing a novel approach to psychiatric meds
October 11, 2022
2022
Better brain biology will deliver better medicines
Subscription Required
Startups are measuring your brain waves and analyzing your voice to figure out how to better treat mental-health disorders like depression
Subscription Required
Better treatments for brain disorders start with knowing what to treat
Subscription Required
December 20, 2021
Better treatments for brain disorders start with knowing what to treat
December 20, 2021
2021
34 healthcare and biotech startups that are set to take off in 2022, according to top investors
Subscription Required
December 20, 2021
34 healthcare and biotech startups that are set to take off in 2022, according to top investors
December 20, 2021
2021
Mental health startup Cerebral teams with Alto Neuroscience to bring 'precision psychiatry' to patients' homes
December 20, 2021
Mental health startup Cerebral teams with Alto Neuroscience to bring 'precision psychiatry' to patients' homes
December 20, 2021
2021
How Cerebral and Alto Neuroscience embarked on an at-home clinical trial for depression
December 20, 2021
How Cerebral and Alto Neuroscience embarked on an at-home clinical trial for depression
December 20, 2021
2021
New RPM Partnership Aims to Test Mental Health Treatments At Home
December 16, 2021
New RPM Partnership Aims to Test Mental Health Treatments At Home
December 16, 2021
2021
From depression to sleep, new era of psychiatric drugs is here, says startup CEO
Subscription Required
October 15, 2021
From depression to sleep, new era of psychiatric drugs is here, says startup CEO
October 15, 2021
2021
Alto Neuroscience Emerges From Stealth With $40M Aimed At Matching Patients And Drugs
October 14, 2021
Alto Neuroscience Emerges From Stealth With $40M Aimed At Matching Patients And Drugs
October 14, 2021
2021
Alto: a computational, biomarker-based approach to neuropsychiatry
Subscription Required
October 14, 2021
Alto: a computational, biomarker-based approach to neuropsychiatry
October 14, 2021
2021
A star Stanford professor leaves his lab for a startup out to remake psychiatry
October 14, 2021
A star Stanford professor leaves his lab for a startup out to remake psychiatry
October 14, 2021
2021
Brain scans could be used to identify who will benefit from antidepressants
February 10, 2020
Brain scans could be used to identify who will benefit from antidepressants
February 10, 2020
2020
How Artificial Intelligence Can Help Pick the Best Depression Treatments for You
February 19, 2020
How Artificial Intelligence Can Help Pick the Best Depression Treatments for You
February 19, 2020
2020
Brain activity can help predict who'll benefit from an antidepressant
February 10, 2020
Brain activity can help predict who'll benefit from an antidepressant
February 10, 2020
2020
Receive updates from Alto
Oops! Something went wrong while submitting the form.